Cargando…

Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen‐specific Th2 response

Detalles Bibliográficos
Autores principales: Kitzmüller, Claudia, Jahn‐Schmid, Beatrice, Kinaciyan, Tamar, Bohle, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767596/
https://www.ncbi.nlm.nih.gov/pubmed/30887520
http://dx.doi.org/10.1111/all.13779
_version_ 1783454954450583552
author Kitzmüller, Claudia
Jahn‐Schmid, Beatrice
Kinaciyan, Tamar
Bohle, Barbara
author_facet Kitzmüller, Claudia
Jahn‐Schmid, Beatrice
Kinaciyan, Tamar
Bohle, Barbara
author_sort Kitzmüller, Claudia
collection PubMed
description
format Online
Article
Text
id pubmed-6767596
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67675962019-10-03 Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen‐specific Th2 response Kitzmüller, Claudia Jahn‐Schmid, Beatrice Kinaciyan, Tamar Bohle, Barbara Allergy Letters to the Editor John Wiley and Sons Inc. 2019-04-10 2019-08 /pmc/articles/PMC6767596/ /pubmed/30887520 http://dx.doi.org/10.1111/all.13779 Text en © 2019 The Authors. Allergy Published by John Wiley and Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Kitzmüller, Claudia
Jahn‐Schmid, Beatrice
Kinaciyan, Tamar
Bohle, Barbara
Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen‐specific Th2 response
title Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen‐specific Th2 response
title_full Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen‐specific Th2 response
title_fullStr Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen‐specific Th2 response
title_full_unstemmed Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen‐specific Th2 response
title_short Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen‐specific Th2 response
title_sort sublingual immunotherapy with recombinant mal d 1 downregulates the allergen‐specific th2 response
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767596/
https://www.ncbi.nlm.nih.gov/pubmed/30887520
http://dx.doi.org/10.1111/all.13779
work_keys_str_mv AT kitzmullerclaudia sublingualimmunotherapywithrecombinantmald1downregulatestheallergenspecificth2response
AT jahnschmidbeatrice sublingualimmunotherapywithrecombinantmald1downregulatestheallergenspecificth2response
AT kinaciyantamar sublingualimmunotherapywithrecombinantmald1downregulatestheallergenspecificth2response
AT bohlebarbara sublingualimmunotherapywithrecombinantmald1downregulatestheallergenspecificth2response